Clinical Trials Logo
  1. Home
  2. Tobacco Use Disorder
  3. NCT00067158
  4. Details
NCT00067158 Clinical Trial

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

Tobacco Use Disorder Clinical Trial

Official title:
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00067158
Other study ID # NIDA-CTN-0009-1
Secondary ID
Status Completed
Phase Phase 3
First received August 12, 2003
Last updated January 11, 2017
Start date April 2003
Est. completion date July 2004

Study information
Verified date April 2010
Source National Institute on Drug Abuse (NIDA)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Recruitment information / eligibility
Status Completed
Enrollment 585
Est. completion date July 2004
Est. primary completion date July 2004
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking

Exclusion Criteria:

- Patient is psychotic

- Use of smokeless tobacco

- Use of other smoking cessasation product

- Pregnancy

- Patient has hyper-tension, heart problems, or skin condition

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• nicotine transdermal system

Locations
Country Name City State
United States Chelsea Arbor Addictions Treatment Center Ann Arbor Michigan
United States Piedmont Behavioral Healthcare Concord North Carolina
United States Psychiatry and Behavioral Medicine Professionals I Detroit Michigan
United States Narco Freedom (Bridge Plaza) Long Island City New York
United States Matrix Institute on Addictions Los Angeles California
United States SPECTRUM Miami Florida
United States Mount Sinai Medical Center New York New York
United States St. Luke's Roosevelt Hospital Center New York New York
United States St. Luke's Roosevelt Hospital Center, Womens New York New York
United States Center for Drug Free Living Orlando Florida
United States Behavioral Health Services of Pickens County Pickens South Carolina
United States Tarzana Treatment Center Tarzana California
United States Coastal Horizons Center, Inc. Wilmington North Carolina

Sponsors (1)
Lead Sponsor Collaborator
New York University

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Drug use
Primary Smoking Cessation
See also
  Status Clinical Trial Phase
Withdrawn NCT02432066 - Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions Phase 2
Completed NCT03960138 - Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Completed NCT04646668 - Comparative Abuse Liability Among African American and White Smokers N/A
Completed NCT02560324 - Effect of Ramelteon on Smoking Abstinence Phase 2
Completed NCT02347605 - Medicinal Nicotine for Preventing Cue Induced Craving N/A
Terminated NCT01800500 - Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers N/A
Completed NCT01625767 - Tobacco Approach Avoidance Training for Adolescent Smokers-1 Phase 2
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01428310 - Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Phase 1
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT00967005 - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers Phase 2
Completed NCT01337817 - A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers Phase 1
Active, not recruiting NCT00751660 - Screening Methods in Finding Lung Cancer Early in Current or Former Smokers N/A
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00664261 - Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking N/A
Completed NCT00218179 - Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 N/A
Completed NCT00134927 - A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches N/A
Completed NCT00158158 - Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2 Phase 2/Phase 3

External Links